Cray to Present at Stifel 2017 Technology Conference
May 30, 2017 20:09 pm UTC| Business
SEATTLE, May 30, 2017 -- Global supercomputer leader Cray Inc. (Nasdaq:CRAY) announced today that Peter Ungaro, President and Chief Executive Officer, and Paul Hiemstra, Corporate Treasurer and Investor Relations, will...
Dermira to Present at Jefferies 2017 Global Healthcare Conference
May 30, 2017 20:08 pm UTC| Business
MENLO PARK, Calif., May 30, 2017 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of...
Dermira to Present at Jefferies 2017 Global Healthcare Conference
May 30, 2017 20:08 pm UTC| Business
MENLO PARK, Calif., May 30, 2017 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of...
Dermira to Present at Jefferies 2017 Global Healthcare Conference
May 30, 2017 20:08 pm UTC| Business
MENLO PARK, Calif., May 30, 2017 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of...
Myriad Genetics to Present at the 2017 Goldman Sachs Global Healthcare Conference
May 30, 2017 20:08 pm UTC| Business
SALT LAKE CITY, May 30, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the...
Myriad Genetics to Present at the 2017 Goldman Sachs Global Healthcare Conference
May 30, 2017 20:08 pm UTC| Business
SALT LAKE CITY, May 30, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the...
Myriad Genetics to Present at the 2017 Goldman Sachs Global Healthcare Conference
May 30, 2017 20:08 pm UTC| Business
SALT LAKE CITY, May 30, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the...
Viksit Bharat 2026: Fiscal Muscle, Factory Revival, and the War on Speculation